Patents by Inventor J. David Leander

J. David Leander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds that inhibit cholinesterase
    Patent number: 8101782
    Abstract: Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: January 24, 2012
    Assignee: Colucid Pharmaceuticals, Inc.
    Inventors: Nadia M. J. Rupniak, James F. White, Kazumi Shiosaki, J. David Leander, Shoucheng Du, Daniel J. Coughlin
  • Compounds that inhibit cholinesterase
    Publication number: 20080261950
    Abstract: Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
    Type: Application
    Filed: February 4, 2008
    Publication date: October 23, 2008
    Applicant: CoLucid Pharmaceuticals, Inc.
    Inventors: Nadia M. J. Rupniak, James F. White, Kazumi Shiosaki, J. David Leander, Shoucheng Du, Daniel J. Coughlin
  • Method of preventing emesis using tetrahydrobenz ?CD!indole-6-carbonxamides
    Patent number: 5703112
    Abstract: The present invention provides methods of preventing emesis and treating sexual dysfunction in mammals utilizing certain tetrahydrobenz?cd!indoles. The invention further provides pharmaceutical formulations suitable for use in such methods.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: December 30, 1997
    Assignee: Eli Lilly and Company
    Inventors: Mark M. Foreman, J. David Leander
  • Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
    Patent number: 4745126
    Abstract: The present invention provides a method of treating anxiety in humans employing a 4-substituted-1,3,4,5-tetrahydrobenz[c,d]indole-6-carboxamide derivative.
    Type: Grant
    Filed: March 12, 1987
    Date of Patent: May 17, 1988
    Assignee: Eli Lilly and Company
    Inventor: J. David Leander